Establishment of an ASPL-TFE3 renal cell carcinoma cell line (S-TFE)

Cancer Biology and Therapy

Volumn 14, Issue 6, 2013, Pages 502-510

  Hirobe, Megumi ^a   Masumori, Naoya ^a   Tanaka, Toshiaki ^a   Kitamura, Hiroshi ^a   Tsukamoto, Taiji ^a  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

Cell line; FISH; Renal neoplasm; TFE3; Translocation; Tumorigenesis; Xp11.2

Indexed keywords

CYTOKERATIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E3; UNCLASSIFIED DRUG; VIMENTIN; ASPSCR1 PROTEIN, HUMAN; BASIC HELIX LOOP HELIX LEUCINE ZIPPER TRANSCRIPTION FACTOR; ONCOPROTEIN; TFE3 PROTEIN, HUMAN;

ADULT; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CARCINOMA CELL; CASE REPORT; CHROMOSOME NUMBER; CHROMOSOME TRANSLOCATION; CHROMOSOME XP; CONTROLLED STUDY; DNA SEQUENCE; DRUG SENSITIVITY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE FUSION; GENE REARRANGEMENT; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; JAPANESE; KIDNEY CARCINOMA; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; X CHROMOSOME; ADOLESCENT; AMINO ACID SEQUENCE; ANIMAL; BAGG ALBINO MOUSE; CANCER TRANSPLANTATION; CARCINOGENESIS; CELL NUCLEUS; CELL PROLIFERATION; CELL SHAPE; EPITHELIUM CELL; GENE TRANSLOCATION; GENETICS; KARYOTYPE; KIDNEY TUMOR; METABOLISM; MOLECULAR GENETICS; MOUSE; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ADOLESCENT; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; CARCINOGENESIS; CARCINOMA, RENAL CELL; CELL LINE, TUMOR; CELL NUCLEUS; CELL PROLIFERATION; CELL SHAPE; EPITHELIAL CELLS; FEMALE; HUMANS; KARYOTYPE; KIDNEY NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, NUDE; MOLECULAR SEQUENCE DATA; NEOPLASM TRANSPLANTATION; ONCOGENE PROTEINS, FUSION; SEQUENCE ANALYSIS, DNA; TRANSLOCATION, GENETIC;

EID: 84879182330     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.24344     Document Type: Article

References (21)

1. Argani P, Ladanyi M. Renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions. In: Eble JN, Sauter G, Epstein JI, et al, eds. Tumors of the Urinary System and Male Genital Organs Lyon: IARC; 2004:37-8.
2. Komai Y, Fujiwara M, Fujii Y, Mukai H, Yonese J, Kawakami S, et al. Adult Xp11 translocation renal cell carcinoma diagnosed by cytogenetics and immunohistochemistry. Clin Cancer Res 2009; 15:1170-6; PMID:19228722; http://dx.doi.org/10.1158/1078-0432.CCR-08-1183.
3. Ramphal R, Pappo A, Zielenska M, Grant R, Ngan BY. Pediatric renal cell carcinoma: clinical, pathologic, and molecular abnormalities associated with the members of the mit transcription factor family. Am J Clin Pathol 2006; 126:349-64; PMID:16880148; http://dx.doi.org/10.1309/98YE9E442AR7LX2X.
4. Bruder E, Passera O, Harms D, Leuschner I, Ladanyi M, Argani P, et al. Morphologic and molecular characterization of renal cell carcinoma in children and young adults. Am J Surg Pathol 2004; 28:1117-32; PMID:15316311; http://dx.doi.org/10.1097/01.pas.0000131558.32412.40.
5. Meyer PN, Clark JI, Flanigan RC, Picken MM. Xp11.2 translocation renal cell carcinoma with very aggressive course in five adults. Am J Clin Pathol 2007; 128:70-9; PMID:17580272; http://dx.doi.org/10.1309/LR5G1VMXPY3G0CUK.
6. Argani P, Lui MY, Couturier J, Bouvier R, Fournet JC, Ladanyi M. A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23). Oncogene 2003; 22:5374-8; PMID:12917640; http://dx.doi.org/10.1038/sj.onc. 1206686.
7. Argani P, Olgac S, Tickoo SK, Goldfischer M, Moch H, Chan DY, et al. Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum. Am J Surg Pathol 2007; 31:1149-60; PMID:17667536; http://dx.doi.org/10.1097/PAS.0b013e318031ffff.
8. Argani P, Lal P, Hutchinson B, Lui MY, Reuter VE, Ladanyi M. Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay. Am J Surg Pathol 2003; 27:750-61; PMID:12766578; http://dx.doi.org/10.1097/00000478-200306000-00005.
9. Ishiguro M, Iwasaki H, Ohjimi Y, Kaneko Y. Establishment and characterization of a renal cell carcinoma cell line (FU-UR-1) with the reciprocal ASPLTFE3 fusion transcript. Oncol Rep 2004; 11:1169-75; PMID:15138551.
10. Hemesath TJ, Steingrímsson E, McGill G, Hansen MJ, Vaught J, Hodgkinson CA, et al. microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family. Genes Dev 1994; 8:2770-80; PMID:7958932; http://dx.doi.org/10.1101/gad.8.22.2770.
11. Argani P, Antonescu CR, Illei PB, Lui MY, Timmons CF, Newbury R, et al. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol 2001; 159:179-92; PMID:11438465; http://dx.doi.org/10.1016/S0002-9440(10)61684-7.
12. Sidhar SK, Clark J, Gill S, Hamoudi R, Crew AJ, Gwilliam R, et al. The t(X;1)(p11.2;q21.2) translocation in papillary renal cell carcinoma fuses a novel gene PRCC to the TFE3 transcription factor gene. Hum Mol Genet 1996; 5:1333-8; PMID:8872474; http://dx.doi.org/10.1093/hmg/5.9.1333.
13. Argani P, Aulmann S, Karanjawala Z, Fraser RB, Ladanyi M, Rodriguez MM. Melanotic Xp11 translocation renal cancers: a distinctive neoplasm with overlapping features of PEComa, carcinoma, and melanoma. Am J Surg Pathol 2009; 33:609-19; PMID:19065101; http://dx.doi.org/10.1097/PAS.0b013e31818fbdff.
14. Ladanyi M, Lui MY, Antonescu CR, Krause-Boehm A, Meindl A, Argani P, et al. The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25. Oncogene 2001; 20:48-57; PMID:11244503; http://dx.doi.org/10.1038/sj.onc.1204074.
15. Noguchi H, Mitsuhashi T, Seki K, Tochigi N, Tsuji M, Shimoda T, et al. Fluorescence in situ hybridization analysis of extraskeletal myxoid chondrosarcomas using EWSR1 and NR4A3 probes. Hum Pathol 2010; 41:336-42; PMID:19775727; http://dx.doi.org/10.1016/j.humpath.2009.04.028.
16. Tamura A, Wakabayashi K, Onishi Y, Takeda M, Ikegami Y, Sawada S, et al. Re-evaluation and functional classification of non-synonymous single nucleotide polymorphisms of the human ATP-binding cassette transporter ABCG2. Cancer Sci 2007; 98:231-9; PMID:17297656; http://dx.doi.org/10.1111/j.1349-7006.2006.00371. x.
17. Argani P, Hawkins A, Griffin CA, Goldstein JD, Haas M, Beckwith JB, et al. A distinctive pediatric renal cell neoplasm characterized by epithelioid morphology, basement membrane production, focal HMB45 immunoreactibvity, and t(6;11)(p21.1;q12) chromosome translocation. Am J Pathol 2001; 1586:2089-96; http://dx.doi.org/10.1016/S0002-9440(10)64680-9.
18. Argani P, Ladanyi M. Translocation carcinomas of the kidney. Clin Lab Med 2005; 25:363-78; PMID:15848741; http://dx.doi.org/10.1016/j.cll.2005.01.008.
19. Suzigan S, Drut R, Faria P, Argani P, De Marzo AM, Barbosa RN, et al. Xp11 translocation carcinoma of the kidney presenting with multilocular cystic renal cell carcinoma-like features. Int J Surg Pathol 2007; 15:199-203; PMID:17478783; http://dx.doi.org/10.1177/1066896906295891.
20. Argani P, Aulmann S, Illei PB, Netto GJ, Ro J, Cho HY, et al. A distinctive subset of PEComas harbors TFE3 gene fusions. Am J Surg Pathol 2010; 34:1395-406; PMID:20871214; http://dx.doi.org/10.1097/PAS.0b013e3181f17ac0.
21. Camparo P, Vasiliu V, Molinie V, Couturier J, Dykema KJ, Petillo D, et al. Renal translocation carcinomas: clinicopathologic, immunohistochemical, and gene expression profiling analysis of 31 cases with a review of the literature. Am J Surg Pathol 2008; 32:656-70; PMID:18344867; http://dx.doi.org/10.1097/PAS. 0b013e3181609914.